B. Brandt
Oncology · 2003–2008
A researcher in the Science corpus: 2 papers; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Oncology — 28 citations into it
- Cancer Research — 22 citations into it
Whom B. Brandt trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from B. Brandt's perspective
Ordered by how strongly the researchers B. Brandt trusts endorse each paper. Same corpus, a different order for every researcher.
- ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. (Cell Stem Cell)
- Dissecting the metastatic cascade (Nature Reviews. Cancer)
- Circulating tumor cells (CTC) detection: clinical impact and future directions. (Cancer Letters)
- Detection of Circulating Tumor Cells in Peripheral Blood of Patients with Metastatic Breast Cancer: A Validation Study of the CellSearch System (Clinical Cancer Research)
- Cancer incidence and mortality in Europe, 2004. (Annals of Oncology)
- American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. (Journal of Clinical Oncology)
- Metastasis: recent discoveries and novel treatment strategies. (The Lancet)
- Circulating Tumor Cell Number and Prognosis in Progressive Castration-Resistant Prostate Cancer (Clinical Cancer Research)
- Circulating Tumor Cells versus Imaging—Predicting Overall Survival in Metastatic Breast Cancer (Clinical Cancer Research)
- Circulating Tumor Cells in Patients with Breast Cancer Dormancy (Clinical Cancer Research)